{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T01:18:12Z","timestamp":1768439892404,"version":"3.49.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T00:00:00Z","timestamp":1657756800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.jneuroim.2022.577930","type":"journal-article","created":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T21:34:01Z","timestamp":1657575241000},"page":"577930","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["The effect of immunosuppression or thymectomy on the response to tetanus revaccination in myasthenia gravis"],"prefix":"10.1016","volume":"370","author":[{"given":"Ellen","family":"Strijbos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monique M.","family":"van Ostaijen-ten Dam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carly","family":"Vervat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco W.","family":"Schilham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maartje G.M.","family":"Huijbers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maarten J.D.","family":"van Tol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan J.G.M.","family":"Verschuuren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2022.577930_bb0005","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1182\/blood-2003-11-3900","article-title":"Functional defect of regulatory CD4(+)CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis","volume":"105","author":"Balandina","year":"2005","journal-title":"Blood."},{"key":"10.1016\/j.jneuroim.2022.577930_bb0010","article-title":"Breakthrough SARS-CoV-2 infections with the delta (B.1.617.2) variant in vaccinated patients with immune-mediated inflammatory diseases using immunosuppressants: a substudy of two prospective cohort studies","volume":"4","author":"Boekel","year":"2022","journal-title":"Lancet Rheumatol."},{"key":"10.1016\/j.jneuroim.2022.577930_bb0015","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1023\/B:JOCI.0000010429.36461.6b","article-title":"Vaccination with rabies to study the humoral and cellular immune response to a T-cell dependent neoantigen in man","volume":"23","author":"Brinkman","year":"2003","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.jneuroim.2022.577930_bb0020","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/BF00863771","article-title":"Changes in peripheral blood lymphocyte subset frequencies in myasthenia gravis patients are related to immunosuppression","volume":"241","author":"Crosti","year":"1994","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2022.577930_bb0025","first-page":"1","article-title":"Safety and tolerability of SARS-Cov-2 vaccination in patients with myasthenia gravis: a multicenter experience","author":"Farina","year":"2022","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jneuroim.2022.577930_bb0030","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1365-2567.2005.02220.x","article-title":"Circulating and thymic CD4 CD25 T regulatory cells in myasthenia gravis: effect of immunosuppressive treatment","volume":"116","author":"Fattorossi","year":"2005","journal-title":"Immunology."},{"key":"10.1016\/j.jneuroim.2022.577930_bb0035","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S1474-4422(15)00145-3","article-title":"Myasthenia gravis: subgroup classification and therapeutic strategies","volume":"14","author":"Gilhus","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2022.577930_bb0040","article-title":"Myasthenia gravis: a review of available treatment approaches","volume":"2011","author":"Gilhus","year":"2011","journal-title":"Autoimmune Dis."},{"key":"10.1016\/j.jneuroim.2022.577930_bb0045","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1196\/annals.1405.027","article-title":"Genetic factors in autoimmune myasthenia gravis","volume":"1132","author":"Giraud","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jneuroim.2022.577930_bb0050","first-page":"656","article-title":"Effect of immunologic treatment on lymphocyte subsets in patients with myasthenia gravis","volume":"38","author":"Han","year":"1999","journal-title":"Zhonghua Nei Ke Za Zhi."},{"key":"10.1016\/j.jneuroim.2022.577930_bb0055","series-title":"Circulating NK cells and their subsets in Behcet\u2019s disease","first-page":"311","volume":"188","author":"Hasan","year":"2017"},{"key":"10.1016\/j.jneuroim.2022.577930_bb0060","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s12883-015-0419-9","article-title":"Feasibility of up-regulating CD4(+)CD25(+) Tregs by IFN-gamma in myasthenia gravis patients","volume":"15","author":"Huang","year":"2015","journal-title":"BMC Neurol."},{"key":"10.1016\/j.jneuroim.2022.577930_bb0065","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/CND.0000000000000133","article-title":"A review of azathioprine-associated hepatotoxicity and myelosuppression in myasthenia gravis","volume":"18","author":"Jack","year":"2016","journal-title":"J. Clin. Neuromuscul. Dis."},{"key":"10.1016\/j.jneuroim.2022.577930_bb0070","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jns.2015.08.029","article-title":"Two-year outcome of thymectomy with or without immunosuppressive treatment in nonthymomatous myasthenia gravis and its effect on regulatory T cells","volume":"358","author":"Jakubikova","year":"2015","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2022.577930_bb0075","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S0198-8859(99)00062-2","article-title":"A susceptibility region for myasthenia gravis extending into the HLA-class I sector telomeric to HLA-C","volume":"60","author":"Janer","year":"1999","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.jneuroim.2022.577930_bb0080","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jneuroim.2013.09.006","article-title":"Disturbed B cell subpopulations and increased plasma cells in myasthenia gravis patients","volume":"264","author":"Kohler","year":"2013","journal-title":"J. Neuroimmunol."},{"issue":"Suppl. 1","key":"10.1016\/j.jneuroim.2022.577930_bb0085","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1002\/ana.410370707","article-title":"Myasthenia gravis: immunological mechanisms and immunotherapy","volume":"37","author":"Lewis","year":"1995","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2022.577930_bb0090","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s10875-017-0414-6","article-title":"Azathioprine-associated complete NK cell deficiency","volume":"37","author":"Orandi","year":"2017","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.jneuroim.2022.577930_bb0095","article-title":"Vaccines and myasthenia gravis: a comprehensive review and retrospective study of SARS-CoV-2 vaccination in a large cohort of myasthenic patients","volume":"1\u201317","author":"Sansone","year":"2022","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2022.577930_bb0100","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000157142","article-title":"Proliferative response of blood cells of patients with myasthenia gravis to purified mammalian acetylcholine receptor","volume":"8","author":"Sisely","year":"1989","journal-title":"Pathol. Immunopathol. Res."},{"key":"10.1016\/j.jneuroim.2022.577930_bb0105","doi-asserted-by":"crossref","first-page":"6290","DOI":"10.1016\/j.vaccine.2017.09.078","article-title":"A prospective, placebo controlled study on the humoral immune response to and safety of tetanus revaccination in myasthenia gravis","volume":"35","author":"Strijbos","year":"2017","journal-title":"Vaccine."},{"key":"10.1016\/j.jneuroim.2022.577930_bb0110","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.vaccine.2019.01.007","article-title":"A prospective, double-blind, randomized, placebo-controlled study on the efficacy and safety of influenza vaccination in myasthenia gravis","volume":"37","author":"Strijbos","year":"2019","journal-title":"Vaccine."},{"key":"10.1016\/j.jneuroim.2022.577930_bb0115","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.clim.2004.04.005","article-title":"Increase of circulating CD4\u00a0+\u00a0CD25+ T cells in myasthenia gravis patients with stability and thymectomy","volume":"112","author":"Sun","year":"2004","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jneuroim.2022.577930_bb0120","first-page":"233","article-title":"The effects of azathioprine and prednisolone on T- and B-lymphocytes in patients with lupus nephritis and chronic glomerulonephritis","volume":"14","author":"Tareyeva","year":"1980","journal-title":"Clin. Nephrol."},{"key":"10.1016\/j.jneuroim.2022.577930_bb0125","series-title":"Tetanus vaccine SPC","year":"2013"},{"key":"10.1016\/j.jneuroim.2022.577930_bb0130","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.clim.2012.09.012","article-title":"Impaired regulatory function in circulating CD4(+)CD25(high)CD127(low\/\u2212) T cells in patients with myasthenia gravis","volume":"145","author":"Thiruppathi","year":"2012","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jneuroim.2022.577930_bb0135","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1749-6632.2012.06840.x","article-title":"Functional defect in regulatory T cells in myasthenia gravis","volume":"1274","author":"Thiruppathi","year":"2012","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jneuroim.2022.577930_bb0140","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1056\/NEJMoa1602489","article-title":"Randomized trial of thymectomy in myasthenia gravis","volume":"375","author":"Wolfe","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2022.577930_bb0145","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3109\/08916934.2014.992517","article-title":"B cells produce less IL-10, IL-6 and TNF-alpha in myasthenia gravis","volume":"48","author":"Yilmaz","year":"2015","journal-title":"Autoimmunity."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572822001254?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572822001254?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:41:46Z","timestamp":1759048906000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572822001254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":29,"alternative-id":["S0165572822001254"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2022.577930","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of immunosuppression or thymectomy on the response to tetanus revaccination in myasthenia gravis","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2022.577930","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"577930"}}